Beutel, Goodman & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $364M | Sell |
3,029,891
-1,032,502
| -25% | -$119M | 2.47% | 11 |
|
|
2025
Q4 | $428M | Sell |
4,062,393
-790,285
| -16% | -$74.2M | 2.63% | 7 |
|
|
2025
Q3 | $407M | Sell |
4,852,678
-251,758
| -5% | -$20.7M | 2.45% | 10 |
|
|
2025
Q2 | $404M | Buy |
5,104,436
+679,339
| +15% | +$54M | 2.3% | 13 |
|
|
2025
Q1 | $397M | Buy |
4,425,097
+383,175
| +9% | +$35.8M | 2.29% | 14 |
|
|
2024
Q4 | $402M | Buy |
4,041,922
+595,105
| +17% | +$61.4M | 2.19% | 11 |
|
|
2024
Q3 | $391M | Buy |
3,446,817
+982,878
| +40% | +$117M | 1.93% | 22 |
|
|
2024
Q2 | $305M | Buy |
2,463,939
+32,099
| +1% | +$4.13M | 1.62% | 29 |
|
|
2024
Q1 | $321M | Buy |
2,431,840
+1,228
| +0.1% | +$151K | 1.65% | 27 |
|
|
2023
Q4 | $265M | Sell |
2,430,612
-1,690
| -0.1% | -$175K | 1.41% | 34 |
|
|
2023
Q3 | $250M | Buy |
2,432,302
+200,856
| +9% | +$21.6M | 1.48% | 33 |
|
|
2023
Q2 | $257M | Buy |
2,231,446
+176,009
| +9% | +$20M | 1.44% | 33 |
|
|
2023
Q1 | $219M | Buy |
2,055,437
+51,000
| +3% | +$5.51M | 1.29% | 39 |
|
|
2022
Q4 | $222M | Sell |
2,004,437
-1,326,189
| -40% | -$136M | 1.35% | 35 |
|
|
2022
Q3 | $287M | Sell |
3,330,626
-571,603
| -15% | -$51M | 1.94% | 22 |
|
|
2022
Q2 | $356M | Sell |
3,902,229
-548,197
| -12% | -$48.6M | 2.21% | 16 |
|
|
2022
Q1 | $365M | Buy |
4,450,426
+124,900
| +3% | +$9.85M | 2.07% | 17 |
|
|
2021
Q4 | $332M | Buy |
4,325,526
+31,225
| +0.7% | +$2.49M | 1.89% | 20 |
|
|
2021
Q3 | $323M | Buy |
4,294,301
+184,220
| +4% | +$14M | 1.97% | 19 |
|
|
2021
Q2 | $320M | Buy |
4,110,081
+592,544
| +17% | +$44.1M | 1.9% | 19 |
|
|
2021
Q1 | $259M | Buy |
3,517,537
+1,387,026
| +65% | +$102M | 1.62% | 24 |
|
|
2020
Q4 | $166M | Buy |
2,130,511
+127,942
| +6% | +$9.79M | 1.13% | 37 |
|
|
2020
Q3 | $159M | Buy |
2,002,569
+375,308
| +23% | +$29.4M | 1.27% | 28 |
|
|
2020
Q2 | $120M | Buy |
1,627,261
+923,166
| +131% | +$69.5M | 0.99% | 39 |
|
|
2020
Q1 | $51.7M | Buy |
704,095
+338,350
| +93% | +$26.6M | 0.48% | 44 |
|
|
2019
Q4 | $31.7M | Sell |
365,745
-192,503
| -34% | -$15.8M | 0.18% | 50 |
|
|
2019
Q3 | $33.9M | Sell |
558,248
-22,085
| -4% | -$1.77M | 0.24% | 50 |
|
|
2019
Q2 | $35.5M | Buy |
580,333
+1,967
| +0.3% | +$151K | 0.26% | 49 |
|
|
2019
Q1 | $34.3M | Buy |
578,366
+9,503
| +2% | +$711K | 0.26% | 47 |
|
|
2018
Q4 | $30.4M | Buy |
568,863
+1,501
| +0.3% | +$106K | 0.26% | 49 |
|
|
2018
Q3 | $29.7M | Sell |
567,362
-288,222
| -34% | -$18.4M | 0.21% | 48 |
|
|
2018
Q2 | $37.7M | Sell |
855,584
-97,628
| -10% | -$5.51M | 0.28% | 46 |
|
|
2018
Q1 | $39.4M | Sell |
953,212
-28,494
| -3% | -$1.54M | 0.3% | 41 |
|
|
2017
Q4 | $42.1M | Buy |
+981,706
| New | +$54.4M | 0.29% | 44 |
|
|
2014
Q3 | – | Sell |
-2,520,318
| Closed | -$130M | – | 31 |
|
|
2014
Q2 | $130M | Buy |
2,520,318
+221,569
| +10% | +$12.1M | 1.11% | 26 |
|
|
2014
Q1 | $138M | Buy |
2,298,749
+62,854
| +3% | +$3.25M | 1.06% | 26 |
|
|
2013
Q4 | $114M | Buy |
+2,235,895
| New | +$102M | 0.99% | 26 |
|
Other funds holding MRK
VCM
VPM
Beutel, Goodman & Co's MRK Position: Q1 2026 in Review
Beutel, Goodman & Co reduced its Merck (MRK) stake by 25% in Q1 2026, selling an estimated $119M and leaving 3,029,891 shares worth $364M. The position accounts for 2.47% of the portfolio, ranked #11.
Beutel, Goodman & Co first reported a position in MRK in Q4 2013 and has held it in 37 quarters since. The position peaked at $428M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Beutel, Goodman & Co held 3,029,891 shares of Merck worth $364M as of Q1 2026.
- Beutel, Goodman & Co sold 1,032,502 Merck shares in Q1 2026, an estimated $119M.
- Merck made up 2.47% of Beutel, Goodman & Co's portfolio in Q1 2026, its #11 holding.
- Beutel, Goodman & Co first reported a position in Merck in Q4 2013 and has held it in 37 quarters since.
- Beutel, Goodman & Co's Merck position peaked at $428M in Q4 2025.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.